BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34858541)

  • 21. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Zhan B; Lu D; Luo P; Wang B
    Clin Lab; 2016 Nov; 62(11):2203-2211. PubMed ID: 28164670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Long Noncoding RNA MALAT-1 is A Novel Biomarker in Various Cancers: A Meta-analysis Based on the GEO Database and Literature.
    Wang Y; Xue D; Li Y; Pan X; Zhang X; Kuang B; Zhou M; Li X; Xiong W; Li G; Zeng Z; Yang T
    J Cancer; 2016; 7(8):991-1001. PubMed ID: 27313790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low Expression LncRNA TUBA4B is a Poor Predictor of Prognosis and Regulates Cell Proliferation in Non-Small Cell Lung Cancer.
    Chen J; Hu L; Wang J; Zhang F; Chen J; Xu G; Wang Y; Pan Q
    Pathol Oncol Res; 2017 Apr; 23(2):265-270. PubMed ID: 27411923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer.
    Luo J; Tang L; Zhang J; Ni J; Zhang HP; Zhang L; Xu JF; Zheng D
    Tumour Biol; 2014 Nov; 35(11):11541-9. PubMed ID: 25129441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
    Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
    Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
    Zhu L; Yu H; Liu SY; Xiao XS; Dong WH; Chen YN; Xu W; Zhu T
    PLoS One; 2015; 10(4):e0124230. PubMed ID: 25905787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) in pancreatic cancer.
    Cheng Y; Imanirad P; Jutooru I; Hedrick E; Jin UH; Rodrigues Hoffman A; Leal de Araujo J; Morpurgo B; Golovko A; Safe S
    PLoS One; 2018; 13(2):e0192264. PubMed ID: 29389953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological significance of DAPK gene promoter hypermethylation in non-small cell lung cancer: A meta-analysis.
    Chen Z; Fan Y; Liu X; Shang X; Qi K; Zhang S
    Int J Biol Markers; 2022 Mar; 37(1):47-57. PubMed ID: 34935548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis.
    Qin K; Hou H; Liang Y; Zhang X
    BMC Cancer; 2020 Apr; 20(1):328. PubMed ID: 32299384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer.
    Sun L; Zhou H; Yang Y; Chen J; Wang Y; She M; Li C
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32329507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between MTA1 Expression and Prognosis of Chinese Lung Cancer 
Patients: A Meta-analysis].
    Zhong H; Tang Y; Wang Y; Gu W
    Zhongguo Fei Ai Za Zhi; 2017 Oct; 20(10):683-689. PubMed ID: 29061215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of long non coding RNAs in non small cell lung cancer: A meta-analysis.
    Wang M; Ma X; Zhu C; Guo L; Li Q; Liu M; Zhang J
    Oncotarget; 2016 Dec; 7(49):81292-81304. PubMed ID: 27833074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis.
    Liu C; Jin J; Shi J; Wang L; Gao Z; Guo T; He Y
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30918102
    [No Abstract]   [Full Text] [Related]  

  • 35. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA JPX correlates with poor prognosis and tumor progression in non-small-cell lung cancer by interacting with miR-145-5p and CCND2.
    Jin M; Ren J; Luo M; You Z; Fang Y; Han Y; Li G; Liu H
    Carcinogenesis; 2020 Jul; 41(5):634-645. PubMed ID: 31253987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer.
    Liu XH; Liu ZL; Sun M; Liu J; Wang ZX; De W
    BMC Cancer; 2013 Oct; 13():464. PubMed ID: 24103700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
    Tan Z; Shen W
    Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer.
    Navarro A; Moises J; Santasusagna S; Marrades RM; Viñolas N; Castellano JJ; Canals J; Muñoz C; Ramírez J; Molins L; Monzo M
    BMC Pulm Med; 2019 Feb; 19(1):55. PubMed ID: 30819158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and validation of long noncoding RNA biomarkers in human non-small-cell lung carcinomas.
    Yu H; Xu Q; Liu F; Ye X; Wang J; Meng X
    J Thorac Oncol; 2015 Apr; 10(4):645-54. PubMed ID: 25590602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.